[go: up one dir, main page]

WO2001045688A3 - Use od desloratadine for treating allergic and inflammatory conditions in pediatric patients - Google Patents

Use od desloratadine for treating allergic and inflammatory conditions in pediatric patients Download PDF

Info

Publication number
WO2001045688A3
WO2001045688A3 PCT/US2000/034418 US0034418W WO0145688A3 WO 2001045688 A3 WO2001045688 A3 WO 2001045688A3 US 0034418 W US0034418 W US 0034418W WO 0145688 A3 WO0145688 A3 WO 0145688A3
Authority
WO
WIPO (PCT)
Prior art keywords
desloratadine
inflammatory conditions
pediatric patients
treating allergic
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/034418
Other languages
French (fr)
Other versions
WO2001045688A2 (en
Inventor
Melton B Affrime
Christopher R Banfield
Samir K Gupta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Priority to AU22773/01A priority Critical patent/AU2277301A/en
Priority to MXPA02006347A priority patent/MXPA02006347A/en
Priority to EP00986552A priority patent/EP1239859A2/en
Priority to JP2001546427A priority patent/JP2003518045A/en
Priority to CA002393837A priority patent/CA2393837A1/en
Publication of WO2001045688A2 publication Critical patent/WO2001045688A2/en
Publication of WO2001045688A3 publication Critical patent/WO2001045688A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The use of desloratadine for the preparation of a medicament for treating and/or preventing an allergic and inflammatory condition of the skin or upper and lower airway passages in a pediatric patient and a pediatric pharmaceutical composition effective for such treating and/or preventing which comprises an effective amount of desloratadine and a pharmaceutically acceptable carrier are disclosed.
PCT/US2000/034418 1999-12-21 2000-12-19 Use od desloratadine for treating allergic and inflammatory conditions in pediatric patients Ceased WO2001045688A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
AU22773/01A AU2277301A (en) 1999-12-21 2000-12-19 Treating allergic and inflammatory conditions
MXPA02006347A MXPA02006347A (en) 1999-12-21 2000-12-19 Treating allergic and inflammatory conditions.
EP00986552A EP1239859A2 (en) 1999-12-21 2000-12-19 Use of desloratadine for treating allergic and inflammatory conditions in pediatric patients
JP2001546427A JP2003518045A (en) 1999-12-21 2000-12-19 Use of desloratadine for the treatment of allergic and inflammatory conditions in pediatric patients
CA002393837A CA2393837A1 (en) 1999-12-21 2000-12-19 Use of desloratadine for treating allergic and inflammatory conditions in pediatric patients

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17291199P 1999-12-21 1999-12-21
US60/172,911 1999-12-21

Publications (2)

Publication Number Publication Date
WO2001045688A2 WO2001045688A2 (en) 2001-06-28
WO2001045688A3 true WO2001045688A3 (en) 2002-05-02

Family

ID=22629711

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/034418 Ceased WO2001045688A2 (en) 1999-12-21 2000-12-19 Use od desloratadine for treating allergic and inflammatory conditions in pediatric patients

Country Status (6)

Country Link
EP (1) EP1239859A2 (en)
JP (1) JP2003518045A (en)
AU (1) AU2277301A (en)
CA (1) CA2393837A1 (en)
MX (1) MXPA02006347A (en)
WO (1) WO2001045688A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
US6863901B2 (en) 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
US5900421A (en) * 1997-02-11 1999-05-04 Sepracor Inc. Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine
WO1999062516A1 (en) * 1998-06-01 1999-12-09 Schering Corporation A stabilized antihistamine syrup containing aminopolycarboxylic acid as stabilizer

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
US5900421A (en) * 1997-02-11 1999-05-04 Sepracor Inc. Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine
WO1999062516A1 (en) * 1998-06-01 1999-12-09 Schering Corporation A stabilized antihistamine syrup containing aminopolycarboxylic acid as stabilizer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"Dictionnaire du Vidal", 1996, EDITIONS DU VIDAL, PARIS, XP002176060 *

Also Published As

Publication number Publication date
JP2003518045A (en) 2003-06-03
EP1239859A2 (en) 2002-09-18
CA2393837A1 (en) 2001-06-28
WO2001045688A2 (en) 2001-06-28
MXPA02006347A (en) 2002-12-13
AU2277301A (en) 2001-07-03

Similar Documents

Publication Publication Date Title
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
IL209703A0 (en) Controlled release hydrocodone formulations
AU1200501A (en) Drug delivery catheters that attach to tissue and methods for their use
IL144730A (en) Use of statin drug in the preparation of a medicament and as a medicament for the treatment of diabetic neuropathy
WO2004028570A3 (en) A method for treating severe tinnitus
EP2514420A3 (en) Use of rapamycin for the treatment or prevention of age-related macular degeneration
WO2001095899A3 (en) Pharmaceutical compositions comprising cannabidiol derivatives
WO2005058233A3 (en) Methods for treatment of acute pancreatitis
CA2294921A1 (en) Levobupivacaine and its use
IL127572A (en) Pharmaceutical composition and medicament for nasal administration
SE9704644D0 (en) New use
NO994165L (en) Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, travel sickness and dizziness
CA2401000A1 (en) Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
AU2002253785A1 (en) Catheter and implants for the delivery of therapeutic agents to tissues
IL149360A0 (en) Method and compositions for administering taxanes orally to human patients
WO2004032858A3 (en) Method for cardioprotection and neuroprotection by intravenous administration of halogenated volatile anesthetics
ZA991749B (en) Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy.
WO2001045715A3 (en) Combinations of an adenosine a1 agonist with an opioid and their use in the treatment of pain
AU1546101A (en) Pharmaceutical compositions comprising acetylcholinesterase antisense deoxynucleotides for the treatment of muscular and neuromuscular disorders
WO2001045688A3 (en) Use od desloratadine for treating allergic and inflammatory conditions in pediatric patients
EP0799618A3 (en) Use of alpha1-adrenoreceptor antagonists in the manufacture of a medicament for the prevention and teatment of cancer
HUP0303597A3 (en) Diposable vaginal cannula for the simultaneous administration of drugs in different forms
HUP0200861A3 (en) Use of n-acetylcysteine for the preparation of a medicament suitable for the intravenous administration to prevent oxidative stress in dialysed patients
HUP0203309A3 (en) Therapeutic combinations of (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino(2,3)-e indol-8-one and neuroleptics for treatment or prevention of phychotic disorders and pharmaceutical compositions containing them
AU7965000A (en) Use of analgesics as digestive and medicines for expectorating and transdermal therapeutic system using the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CZ DE DK DM DZ EE ES FI GB GD GE HR HU ID IL IN IS JP KG KR KZ LC LK LR LT LU LV MA MD MG MK MN MX MZ NO NZ PL PT RO RU SE SG SI SK SL TJ TM TR TT TZ UA US UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 10130763

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2393837

Country of ref document: CA

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 546427

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2000986552

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: PA/a/2002/006347

Country of ref document: MX

WWP Wipo information: published in national office

Ref document number: 2000986552

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWR Wipo information: refused in national office

Ref document number: 2000986552

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2000986552

Country of ref document: EP